Premier Anti-aging Co., Ltd. (4934) Press Release
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending July 31, 2026
Earlier from Premier Anti-aging
- Premier Anti Aging: Summary of Financial Results for the third quarter 2022
- Premier Anti Aging: Notice of Revision of Consolidated Earnings Forecasts for the Fiscal Year Ending July 31, 2022
- Premier Anti Aging: FY2022 3Q Results Briefing Material
- Premier Anti Aging: This is an announcement regarding an exclusive license agreement with sublicensing rights of DDS technology DehydraTECH TM by the group company.